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httpcense.Abstract Background: Diagnostic value of echopulmonography (EPG) in chest diseases is
expanding as a guide to discriminate between benign and malignant parenchymal lesions as regards
tissue characterization plus pleural lesions’ diagnostic speciﬁcation.
Objectives: To determine echopulmonography predictors of malignancy in patients with periph-
eral pulmonary and solid pleural lesions.
Patients and methods: A prospective clinical study was conducted on 122 patients who presented
with peripheral pulmonary and pleural lesions by chest X-ray. They underwent echopulmonogra-
phy and CT chest evaluation. Patients were divided into two groups: Group (1), 63 patients diag-
nosed by CT chest and CT guided biopsy followed by EPG. Group (2), 59 patients diagnosed by
EPG and ultrasound (US) guided biopsy followed by CT chest. Tissue biopsy was taken either
through CT guided biopsy or ultrasound guided biopsy for pathological examination.rer. Tel.: +20 01008424320.
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128 S.A.M.A. Elhafez et al.Results: EPG had a success rate of 75.9% in diagnosing malignancy and 17.2% in diagnosing
nonmalignant lesions. Success rate of EPG based diagnosis in all studied cases was 45%. Using
EPG criteria; rounded and oval morphology was statistically signiﬁcantly higher in malignant than
nonmalignant subgroups (53.4% versus 32.8%) in contrast to irregular morphology with ramiﬁca-
tions that prevailed in the nonmalignant subgroup (67.2% versus 46.5%). Irregular pleural contour
and heterogeneous hypoechogenicity were predominant in the nonmalignant subgroup (67.1% and
28.1%, respectively). Echoinvasion, destruction of normal tissue architecture and blood vessels dis-
placement were more common in malignant than nonmalignant subgroups.
Conclusion: Echopulmonography has a worthy role in differentiating benign from malignant
peripheral pulmonary and pleural lesions. US guided biopsy is performed with a low risk of com-
plications.
Crown Copyright ª 2013 Published by Elsevier Company on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. Open access under CC BY-NC-ND license.Introduction
Echopulmonography ‘‘EPG’’ (transthoracic ultrasound, TUS)
has become an important diagnostic tool in modern chest med-
icine in differentiation between benign and malignant neo-
plasms of the lung, pleura and peridiaphragmatic lesions [1].
With the improvement of resolution in ultrasonic equip-
ment and its puncture probe, ultrasonically guided aspiration
biopsy has recently been performed in the diagnosis of various
diseases in the lung. Many ultrasonographic features and signs
of chest diseases have been characterized and widely applied in
clinical practice [2].
The usefulness of ultrasonography has now been demon-
strated in many pulmonary and pleural diseases because it of-
fers a number of advantages over other radiologic imaging
technologies, including the absence of ionizing radiation, the
accessibility of the necessary equipment, and the possibility
of real-time bedside applications and image assessment. These
characteristics are especially useful in patients who are partic-
ularly susceptible to the adverse effects of radiation, such as
children and pregnant women, and in patients who can only
be moved with difﬁculty, such as those in intensive care units.
Because ultrasound scanners are portable, they can also be
used by emergency response teams to evaluate patients outside
of the hospital setting [3]. Thus, this study was conducted to
evaluate the role of EPG in differentiation between benign
and malignant peripheral pulmonary and solid pleural lesions
to determine predictors of malignancy.
Patients and methods
This comparative study included 122 patients with peripheral
pulmonary and solid pleural lesions. They were divided into
two groups:
Group I: included 63 patients diagnosed by CT chest and
percutaneous CT guided biopsy followed by EPG without
prior knowledge of their CT biopsy results.
Group II: included 59 patients diagnosed by EPG and ultra-
sound guided biopsy followed by CT chest examination with-
out prior knowledge of their ultrasound guided biopsy results.
These two groups are further subdivided into two sub-
groups as malignant and nonmalignant according to ﬁnal
diagnosis.Inclusion criteria
Patients with peripheral pulmonary and/ or solid pleural
lesions.
Peripheral pulmonary lesion: deﬁned radiologically accord-
ing to Radke et al. [4] as a lesion or opacity close to the chest
wall either in:
(1) Outer third of plain chest X-ray (CXR), posteroanterior
(PA) ﬁlm.
(2) Anterior or posterior third of plain CXR, lateral ﬁlm.
(3) Apex of the lung.
(4) Peridiaphragmatic areas.
Solid pleural lesion: denotes compact non cystic lesions of
the pleura.
Exclusion criteria
Patients with:-
– Free pleural effusion.
– Pneumothorax.
– Chest wall lesions.
Final diagnosis: included pathological diagnosis by CT
guided, US guided biopsies and patient follow up.
All cases were subjected to full history taking, clinical
examination and routine laboratory investigations and ﬁber-
optic bronchoscopy (FOB) in certain cases with associated cen-
tral pulmonary lesions or if the lesion was large to extend to
the hilum; nine cases performed FOB (seven in the malignant
subgroup and two in nonmalignant one). EPG was performed
using a micro-convex low frequency two dimensional ultra-
sound probe (2.5–5 MHz) of (Mindray DP 2200) ultrasound
unit. Most examinations were performed in staged approach;
ﬁrst, with the patient in supine position, second with the pa-
tient in lateral decubitus, third with patient in sitting position
from front and back to enable the improved intercostal win-
dows. Conventional CT chest with contrast was performed
in most cases apart from cases suspected as pulmonary
AVM and pulmonary embolism that performed CT
angiography.
Echopulmonography versus computed tomographic chest predictors for differentiation between benign and malignant 129Predictors of malignancy
Clinical predictors of pleuro-pulmonary malignancy according
to Ferrer et al. [5] were age more than 50 years, positive smok-
ing history, absence of fever, history of previous malignancy
and duration of illness >1 month.
FOB signs suggestive of malignancy adopted in our study
according to Tsaubi et al. [6] were four types of tumor–bron-
chus relationships. First, if the bronchial lumen is patent up
to the tumor. Second, if the bronchus is contained in the tumor
mass. Third, if the bronchus is compressed and narrowed by
the tumor with intact bronchial mucosa. Fourth, if the proxi-
mal bronchial tree is narrowed by peribronchial or submucosal
spread of the tumor or by enlarged lymph nodes.
Computed tomography (CT) ﬁndings suggestive of malig-
nancy adopted in this study according to Arenas et al. [7], were
chest wall invasion, pleural nodules, pleural nodular thicken-
ing >1 cm pulmonary mass, pulmonary cavity with shaggy
irregular wall and mediastinal lymphadenopathy.
Echopulmonographic predictors of malignancy imple-
mented in our study according to Mathis [8], were ﬁrst, malig-
nant morphology; rounded/oval or irregular with ramiﬁcation,
second, uneven contour of the pleural surface with irregular
deformation due to invasion by a lung carcinoma, third inva-
sion of adjacent structures (chest wall, diaphragm and pericar-
dium) fourth, destruction of normal tissue architecture, ﬁfth,
heterogeneous hypoechogenicity and sixth, blood vessels dis-
placement, destruction and/or neovascularization by Doppler
ultrasound.
Statistical analysis
Data was analyzed using SPSS (Statistical Package for Social
Sciences) version 16. Qualitative data was presented as number
and percentage. Quantitative data was presented for normality
by Kolmogrov–Smirnov test. Normally distributed data was
presented as mean and standard deviation. Comparison be-
tween groups was done using the Chi-square test. Student’s
t-test was used to compare between two groups. p value < 0.05
was considered signiﬁcant.
Sensitivity ¼ Corrected positive by the test=True positive
Specificity ¼ Corrected negative by the test=True negative
J index ¼ ðSensitivityþ SpecificityÞ  100
Positive predicted value ðPPVÞ : True positive by the test
=ðTrue positiveþ False positiveÞ
Negative predicted value ðNPVÞ : True negative by the test
=ðTrue negativeþ False negativeÞ
PPV and NPV indicate diagnostic probability as regards
positivity and negativity.
Agreement: It is the acceptance of the maneuver based on
diagnostic matching between applied maneuver and the ﬁnal
results approached by all means.Kappa = It is the measure-
ment of agreement of the test
Kappa test scored between 0 and 1
0.0–0.50ﬁ very weak agreement
0.50–0.65ﬁ weak agreement
0.65–0.75ﬁ good agreement0.75–0.85ﬁ very good agreement
0.85–0.95ﬁ excellent agreement
1ﬁ exact agreement
Accuracy ¼ Corrected diagnosed cases
Total cases studiedResults
Our study was conducted on 122 patients (86 males and 36 fe-
males). Mean age was 53.89 ± 14.50 years (range 15–85 years) in
total cases studied. Thirty-seven cases were non smokers, 60 cases
were current smokers while 22 cases were ex-smokers, and passive
smokers were three cases only in our study population.
As shown in Table 1 mean age of patients in group I was
53.56 ± 12.13 years and 54.12 ± 13.02 years in group II with
a non-signiﬁcant statistical difference. Mean age of patients
in the malignant subgroup was 53.03 ± 13.23 years, while it
was 54.45 ± 13.48 years in the nonmalignant subgroup with
a non-signiﬁcant statistical difference. Patients in group I,
had higher number in males than females (44 and 19 respec-
tively), group II patients also had more males than females
(42 and 17 respectively) with a non-signiﬁcant statistical differ-
ence as regards sex. The malignant subgroup comprised 41
males and 17 females, the nonmalignant subgroup comprised
45 males and 19 females with higher predominance of males
in both subgroups with a non-signiﬁcant statistical difference
(p value = 0.964).
As regards smoking history, twenty-two non smokers, 28
current smokers, three passive smokers and 10 ex-smokers
were enrolled in group I while group II had 15 nonsmokers,
32 current smokers, and 12 ex-smokers but no passive smokers
was present with a non-signiﬁcant statistical difference be-
tween two groups. Malignant subgroup enrolled the highest
percentage of smokers (current + passive + ex-smokers)
(75.8%), on the contrary to the nonmalignant subgroup
(64%), while non smokers were higher in the nonmalignant
subgroup than malignant one (35.9% versus 24.1% respec-
tively) with a non-signiﬁcant statistical difference. From previ-
ous data, both groups I and II were comparable to each other
owing to the absence of signiﬁcant statistical differences as re-
gards age, sex and smoking history.
Table 2 and Fig. 1 show predictors of malignancy. Clinical
predictors of malignancy were age >50 years, smoking his-
tory, absence of fever, history of previous malignancy and
duration of illness >1 month. They were prevalent in the
malignant subgroup (69%, 75.9%, 65.5%, 12.1% and
55.17%, respectively for each predictor) than nonmalignant
one but with a non-signiﬁcant statistical difference between
two subgroups. Regarding FOB ﬁndings suggestive of malig-
nancy, malignant subgroup had higher endoscopic ﬁndings
suggestive of malignancy than nonmalignant one (77.8% ver-
sus 22.2%) respectively, with a signiﬁcant statistical difference
(p value = 0.001). By summation of all clinical and FOB pre-
dictors of malignancy, they were found in ﬁve cases of our
study, four of them proved by biopsy (CT or US guided) to
be malignant accounting for 80% diagnostic yield and one
proved to be nonmalignant with a signiﬁcant statistical differ-
ence (p= 0.011).
Table 1 Age, sex and smoking history in studied cases.
Group I n= 63 Group II n= 59 p Value Malignant subgroup (n= 58) Non-malignant subgroup (n= 64) p Value
Age 53.56 ± 12.13 54.12 ± 13.02 0.832 53.03 ± 13.23 54.45 ± 13.48 0.875
Sex
Male 44 (69.8%) 42 (71.1%) 0.152 41 (70.6%) 45 (70.3%) 0.964
Female 19 (30.2%) 17 (28.8%) 17 (29.4%) 19 (29.6%)
Smoking
Non smoker 22 (34.9%) 15 (25.4%) 0.178 14 (24.1%) 23 (35.9%) 0.162
Current smoker 28 (44.4%) 32 (54.2%) 29 (50%) 31 (48.4%)
Passive smoker 3 (4.7%) 0 (0%) 1 (1.7%) 2 (3.1%)
Ex-smoker 10 (15.9%) 12 (20.3%) 14 (24.1%) 8 (12.5%)
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cantly higher in malignant than nonmalignant subgroups were
pulmonary mass (77.6% versus 34.3%) with (p 6 0.001), medi-
astinal lymphadenopathy (48.3% versus 15.6%) with
(p 6 0.001) followed by pulmonary cavitation (14.06% versus
1.7%) with (p= 0.013). On the other side pleural nodules were
statistically signiﬁcantly higher in nonmalignant than the
malignant subgroup (17.1% versus 5.2%) with (p= 0.038).
There were non-signiﬁcant statistical differences between two
subgroups as regards pleural nodular thickening and chest wall
invasion.
Using EPG criteria, rounded and oval morphology was sta-
tistically signiﬁcantly higher in malignant than the nonmalig-
nant subgroup (53.4% versus 32.8%) with (p= 0.021) in
contrast to irregular morphology with ramiﬁcations that pre-
vailed in the nonmalignant subgroup (67.2% versus 46.5%).
Irregular pleural contour and heterogeneous hypoechogenicity
were predominant in the nonmalignant subgroup (67.1% and
28.1%, respectively) with a non-signiﬁcant statistical differ-
ence. On the other side echoinvasion, destruction of normal
tissue architecture, blood vessels displacement were more com-
mon in malignant than the nonmalignant subgroup (24.1%
versus 20.3% in each predictor).
Table 3 shows that the relation between CT chest based
diagnosis of malignancy and ﬁnal diagnosis of malignant le-
sions presented a very weak agreement of CT based diagnosis
in both groups I and II and total cases {Kappa = 0.066, 0.190
and 0.128, respectively}. CT chest succeeded in diagnosis of
50% of malignant lesions and 56.8% of nonmalignant lesions
in group I as ﬁnal diagnosis while it succeeded in diagnosing
56.2% of malignant lesions and 63% of nonmalignant lesions
in group II. Totally CT chest had a success rate of 53.4% in
diagnosing malignancy and 59.4% in diagnosing nonmalig-
nant lesions in total studied cases. CT chest showed a higher
capability in diagnosing nonmalignant rather than malignant
lesions. CT chest established the diagnosis in (13 cases of
malignant lesions + 21 cases of nonmalignant lesions) = 34
patients out of 63 in group I with success rate of 54% however,
established the diagnosis in (18 cases of malignant le-
sions + 17 cases of nonmalignant lesions) = 35 patients out
of 59 in group II with success rate of 59.3%. So, total success
rate of CT chest based diagnosis in all studied cases was
(34 + 35)/122 = 56.6%.
Also as shown in Table 3 the relation between EPG based
diagnosis of malignancy versus ﬁnal diagnosis of malignant le-
sions presented a very weak agreement of EPG based diagnosis
in both groups I and II and total cases {Kappa = 0.186, 0.069and 0.067, respectively}. EPG succeeded in diagnosis of 65.4%
of malignant lesions and 13.5% of nonmalignant lesions in
group I as ﬁnal diagnosis while it succeeded in diagnosing
84.4% of malignant lesions and 22.2% of nonmalignant le-
sions in group II. Totally EPG had a success rate of 75.9%
in diagnosing malignancy and 17.2% in diagnosing nonmalig-
nant lesions in total studied cases. EPG showed a higher capa-
bility in diagnosing malignant rather than nonmalignant
lesions. EPG established the diagnosis in (5 cases of nonmalig-
nant + 17 cases of malignant) = 22 cases out of 63 patients of
group I with success rate of 35%, however, established diagno-
sis in (6 cases of nonmalignant + 27 cases of malignant) = 33
out of 59 patients of group II with success rate of 56%. So, a
total success rate of EPG based diagnosis in all studied cases
was (22 + 33)/122 = 45%.
ðCorrected diagnosis ¼ diagnosis matched by the tested
method versus final diagnosisÞ
Table 4 shows that CT chest established the diagnosis in 35
cases (28.7%) with the ﬁnal diagnosis that were not reached by
EPG. On the contrary EPG ascertained the diagnosis in 21
cases (17.2%) with the ﬁnal diagnosis that were not diagnosed
by CT chest. Both EPG and CT chest agreed in establishing
the diagnosis (whether malignant or nonmalignant) in 34 cases
(27.9%) with the ﬁnal diagnosis but both disagreed in 32 cases
(26.2%) with the ﬁnal diagnosis.
Table 5 shows that adding these four predictors (clinical,
FOB, CT chest and EPG) collectively increased the probability
of diagnosis of malignancy in 67.2% of cases diagnosed with
malignancy and possibility to exclude malignancy in 71.8%
of cases that were nonmalignant with success rate of 69.7%
of total cases.
NB
The predictor was considered being positive if more than one
criterion present in diagnosed case.
Table 6 shows that sensitivity of EPG was higher than CT
chest (75.86% and 53.45%, respectively) in the diagnosis of to-
tal studied cases while speciﬁcity of CT chest in total cases
studied was higher than EPG (59.38% and 17.19%, respec-
tively). Accuracy of CT chest was higher than EPG (56.56%
and 45.08%, respectively) in total cases studied. PPV and
NPV were higher in CT chest in total cases (54.39% and
58.46%, respectively) than those for EPG (45.63% and 44%,
respectively).
Table 2 Clinical, FOB, CT chest and EPG predictors of malignancy in both subgroups.
Predictors of malignancy Malignant subgroup
(n= 58)
Non-malignant subgroup
(n= 64)
p
Value
Clinical predictors of malignancy
Age > 50 years 40 (69%) 33 (51.5%) 0.833
Smoking history 44 (75.9%) 41 (64%) 0.157
Absence of fever 38 (65.5%) 23 (35.9%) 0.712
History of previous malignancy 7 (12.1%) 3 (4.6%) 0.942
Duration of illness > 1 month 32 (%55.17) 32 (50%) 0.135
FOB predictors of malignancy
FOB ﬁndings suggestive of malignancy (No = 9
cases)
7 (77.8%) 2 (22.2%) 0.001
No of cases showed (all clinical + FOB
predictors) (No = 5 cases)
4 (80%) 1 (20%) 0.011
CT predictors of malignancy
Chest wall invasion 2 (3.6%) 0 (0%) 0.202
Pleural nodules 3 (5.2%) 11 (17.1%) 0.038
Pleural nodular thickening > 1 cm 0 (0%) 2 (3.12%) 0.175
Pulmonary mass 45 (77.6%) 22 (34.3%) <0.001
Pulmonary cavity 9 (14.06%) 1 (1.7%) 0.013
Mediastinal lymphadenopathy 28 (48.3%) 10 (15.6%) <0.001
EPG predictors of malignancy
Malignant morphology
Rounded/oval 31 (53.4%) 21 (32.8%) 0.021
Irregular with ramiﬁcations 27 (46.5%) 43 (67.2)
Heterogeneous hypoechogenicity 13 (22.4%) 18 (28.1%) 0.469
Echoinvasion of surroundings 14 (24.1%) 13 (20.3%) 0.611
Destruction of normal tissue architecture 14 (24.1%) 13 (20.3%) 0.611
Displacement and destruction of blood vessels 14 (24.1%) 13 (20.3%) 0.611
Irregular contour of the pleural surface 32 (55.1%) 43 (67.1%) 0.187
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Echopulmonography (EPG) has become an important diag-
nostic modality in pulmonary practice. The range of thoracic
lesions for which EPG may yield useful diagnostic informa-
tion has expanded to include not only chest wall and pleural
lesions, but also peripheral lung nodules, pulmonary consol-
idations, pneumonias, lung abscesses and tumors. Thus, this
study was conducted to evaluate the role of EPG in differ-
entiation between benign and malignant peripheral pulmon-
ary and solid pleural lesions to determine predictors of
malignancy.
Clinical and FOB predictors of malignancy
In our study, in accordance with Ferrer et al. [5], age
>50 years, smoking history, absence of fever, history of pre-
vious malignancy and duration of illness >1 month were
prevalent in the malignant subgroup than nonmalignant
one (69%, 75.9%, 65.5%, 12.1% and 55.17%, respectively
for each predictor) but with non-signiﬁcant statistical differ-
ences between two subgroups although these predictors may
reﬂect the higher incidence in malignant cases on clinical
background. Similarly, Gurney et al. [9] conﬁrmed that spe-
ciﬁc clinical features affect the likelihood of benignancy or
malignancy, however, and in conjunction with imaging char-
acteristics of the lesion, both can impact the diagnostic ap-
proach and the choice of therapeutic options. The clinicalfactors to consider in evaluating the likelihood of malig-
nancy in a peripheral pulmonary lesion included patient
age, smoking history; severe pulmonary symptoms, comor-
bid conditions, history, type of prior malignancy and envi-
ronmental exposures.
On the contrary, Yankelevitz et al. [10] stated that as in
many areas of clinical practice, semiquantitative techniques
and analysis of the likelihood of benignancy or malignancy
of solitary pulmonary nodule, had not gained widespread use
because of the large number of variables to be estimated and
differences in local practice.
FOB ﬁndings suggestive of malignancy adopted in our
study according to Tsaubi et al. [6] criteria showed that nine
cases presented positive FOB ﬁndings suggestive of malig-
nancy; seven cases only in the malignant subgroup as most
of these malignant lesions were in peripheral locations (three
cases with endobronchial tumor mass, two cases with bron-
chial wall compression and two cases with their bronchus con-
tained in the tumor) and two cases in the nonmalignant
subgroup due to bronchial wall compression by enlarged medi-
astinal LN. Malignant subgroup had higher endoscopic ﬁnd-
ings suggestive of malignancy than nonmalignant one
(77.8%) and (22.2%) respectively, with a signiﬁcant statistical
difference (p value = 0.001).
By summation of all clinical and FOB predictors of malig-
nancy, they were found in ﬁve cases of our study, four of them
proved by biopsy (CT or US guided) to be malignant account-
ing for 80% diagnostic yield with a signiﬁcant statistical differ-
ence (p value = 0.011).
Figure 1 Clinical, FOB, CT chest and EPG predictors of malignancy.
132 S.A.M.A. Elhafez et al.CT chest predictors of malignancy
In our patients, CT predictors of malignancy according to Are-
nas et al. [7], were statistically signiﬁcant in malignant than
nonmalignant subgroups including pulmonary mass (77.6%
versus 34.3%) with (p 6 0.001), mediastinal lymphadenopathy
(48.3% versus 15.6%) with (p 6 0.001) followed by pulmonary
cavitation (14.06% versus 1.7%) with (p= 0.013) on one
hand. On the other hand, pleural nodules were statistically sig-
niﬁcantly higher in nonmalignant than malignant subgroups
(17.1% versus 5.2%) with (p= 0.038) respectively. These pleu-
ral nodules and thickening were detected in tuberculosis pa-
tients. There were non-signiﬁcant statistical differences
between two subgroups as regards pleural nodular thickening
and chest wall invasion.
Likewise, ﬁndings suggestive of malignancy by CT chest
were studied by Auerbach and Garﬁnkel [11], who stated thatTable 3 Evaluation of EPG versus CT chest in contrast to ﬁnal di
Final diagnosis CT chest based diagnosis
Malignant (n= 58) Non-malignant (n= 64
Group I (n = 63)
Malignant n= 58 13 (50%) 13 (50%)
Non-malignant n= 64 16 (43.2%) 21 (56.8%)
Total 29 (46%) 34 (54%)
Kappa 0.066
GROUP II n = 59
Malignant n= 58 18 (56.2%) 14 (43.8%)
Non-malignant n= 64 10 (37%) 17 (63%)
Total 28 (47.5%) 31 (52.5%)
Kappa 0.190
Total cases n = 122
Malignant n= 58 31 (53.4%) 27 (46.6%)
Non-malignant n= 64 26 (40.6%) 38 (59.4%)
Total 57 (46.7%) 65 (53.3%)
KAPPA 0.128
Total success rate 56.6%approximately 40% of bronchial carcinomas arose beyond the
segmental bronchi and in 30% a peripheral mass was the sole
radiographic ﬁnding. The majority of peripheral lung cancers
were approximately spherical or oval in shape. Heitzman
et al. [12] found that lobulation, a sign that indicated uneven
growth rates in different parts of the tumor was highly sugges-
tive of bronchial carcinoma.
Mahoney et al. [13] and Grewal and Austin [14] found
that peripheral lung cancers, notably adenocarcinoma and
bronchoalveolar carcinoma, had ill-deﬁned edges similar to
pneumonia. Cavitation may be identiﬁed in tumors of any
size, walls of the cavitations were of irregular thickness
and may contain tumor nodules, but sometimes the wall
had smooth inner and outer margins. We found that pul-
monary cavitation accounted for 14.06% in malignant ver-
sus 1.7% in the nonmalignant subgroup due to secondary
changes of the tumor.agnosis in assessment of malignancy.
Total EPG based diagnosis Total
) Malignant (n= 58) Non-malignant (n= 64)
26 17 (65.4%) 9 (34.6%) 26
37 32 (86.5%) 5 (13.5%) 37
63 49 (77.8%) 14 (22.2%) 63
0.186
32 27 (84.4%) 5 (15.6%) 32
27 21 (77.8%) 6 (22.2%) 27
59 48 (81.4%) 11 (18.6%) 59
0.069
58 44 (75.9%) 14 (24.1%) 58
64 53 (82.8%) 11 (17.2%) 64
122 97 (79.5%) 25 (20.5%) 122
0.067
45%
Table 4 EPG corrected diagnosis versus CT chest corrected diagnosis in all studied cases.
CT chest corrected diagnosis Total
No Yes
Number and %
EPG corrected diagnosis
No 32 (26.2%) 35 (28.7%) 67 (54.9%)
Yes 21 (17.2%) 34 (27.9%) 55 (45.1%)
Total 53 (43.4%) 69 (56.6%) 122 (100%)
Table 5 Discriminate analysis of all predictors.
Classiﬁcation results
Predicted group membership Total
Non-malignant Malignant
Final diagnosis No. and (%)
Non-malignant 46 (71.8%) 18 (28.1%) 64
Malignant 19 (32.75%) 39 (67.2%) 58
69.7% of original grouped cases correctly classiﬁed.
(46 + 39/122).
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the presence of chest wall invasion by CT chest adjacent to a
tumor was an unreliable ﬁnding, unless there was a clear-cut
bone destruction or a large soft tissue mass. As regards contact
with the pleura on CT examination, even if the pleura was
thickened it did not necessarily indicate invasion, though the
greater the degree of contact and the greater the pleural thick-
ening, the more likely the parietal pleura had been invaded.
Bury et al. [17], Erasmus et al. [18] and Schafﬂer et al. [19] con-
ﬁrmed that pleural involvement may occur as a result of direct
spread, lymphatic involvement, or tumor emboli and might
present with pleural effusion in association with a primary
lung cancer in 91% of cases. In our cases chest wall invasion
was detected in the malignant subgroup only (3.6%), on the
other hand pleural nodules and pleural nodular thickening
were prevalent in the nonmalignant subgroup (17.1% and
3.125%).
Tateishi et al. [20], demonstrated that lung cancers usually
extend to ipsilateral hilar lymph nodes, ipsilateral mediastinal,
contralateral mediastinal and supraclavicular lymph nodes.
Buy et al. [21] dedicated that a reasonable generalization was
that both sensitivity and speciﬁcity of lymph node size were
in the 50–60% range when the cut-off point for normal was
a short axis diameter of 1 cm. In a similar way, mediastinal
lymphadenopathy was detected in 48.3% of malignant versusTable 6 Statistical predictors of EPG and CT chest in studied case
Test Sensitivity (%) Speciﬁcity (%)
EPG in group I 65.38 13.51
CT chest in group I 50 56.76
EPG in group II 84.38 22.22
CT chest in group II 56.25 62.96
EPG in total cases 75.86 17.19
CT chest in total cases 53.45 59.3815.6% in nonmalignant subgroups in our study population
depending on standard lymph node size of 1.5 cm.
The National Lung Screening Trial (NLST) [22], a random-
ized trial compared screening by chest CT scanning versus CT
guided biopsy for three years in high risk persons. Lung can-
cers detected by CT scanning were mostly 70% of CT-cases
by detecting lung nodule, pulmonary mass with mediastinal
lymphadenopathy and chest wall invasion. Their total success
rate of CT chest was 54% in contrast to CT guided biopsy that
accounted for 88%. They matched with the total success rate
of CT chest criteria in our study that was 53.4% in diagnosing
malignancy.
Correspondingly, in our study, CT chest criteria succeeded
in the diagnosis of 50% of malignant lesions and 56.8% on
nonmalignant lesions in group I as ﬁnal diagnosis while it
succeeded in diagnosing 56.2% of malignant lesions and
63% of nonmalignant lesions in group II. Totally CT chest
had a success rate of 53.4% in diagnosing malignancy and
59.4% in diagnosing nonmalignant lesions. CT chest estab-
lished diagnosis in group I (malignant and nonmalignant)
with a success rate of 54% however, established diagnosis
in group II with a success rate of 59.3%. Total success rate
of CT chest based diagnosis in all studied cases was 56.6%
as shown in Table 3. CT chest established the diagnosis in
35 cases with ﬁnal diagnoses that were not reached by EPG
as shown in Table 4. So it is likely to say that CT chest
showed a higher capability in diagnosing nonmalignant
rather than malignant lesions.
EPG predictors of malignancy
EPG diagnosis depended on the ultrasonic visualization of the
lesion, penetration of ultrasound, and hence, visualization of a
mass was prevented by almost any layer of aerated lung which
was located between the mass and the transducer. The diagno-
sis of benign disease was more difﬁcult to establish by EPG
because it requires more lesion characterization than in malig-
nant lesion [23].s.
J index Accuracy (%) Kappa PPV NPV
21.11 35 0.186 34.69 35.71
6.76 54 0.066 44.83 61.76
6.6 56 0.069 56.25 54.55
19.21 59.32 0.19 64.29 54.84
6.95 45.08 0.067 45.63 44
12.83 56.56 0.128 54.39 58.46
134 S.A.M.A. Elhafez et al.In the present study, using EPG criteria along with Mathis
[8]; we observe that rounded and oval morphology was statis-
tically signiﬁcantly higher in malignant than nonmalignant
subgroups (53.4% versus 32.8%) with (p= 0.021) in contrast
to irregular morphology with ramiﬁcations that prevailed in
the nonmalignant subgroup (67.2% versus 46.5%). In a study
done by Begum et al. [24], with TUS dedicated that irregular
margin was seen in some benign lesions including tuberculosis
and pneumonia but prevailed in malignant lesions while rib
erosion and mediastinal invasion were predominant in malig-
nant lesions only. Metastases of >5 mm in diameter on the
parietal or diaphragmatic pleura can be detected by US. These
nodules were round, oval, broad-based, echogenic or moder-
ately echogenic, and well delineated against effusion. A sign
of invasion in the underlying chest wall or lung may be a poor
demarcation or fringed ramiﬁcations into the underlying tissue
[25]. This explained that irregular margin in malignancy de-
noted inﬁltrations and or invasion by tissue spread.
In our study, irregular pleural contour, unlikely, was pre-
dominant in the nonmalignant subgroup (67.1%) followed
by the malignant subgroup (55.1%), explained by fragmenta-
tions in the pleural line in cases of infections and not actual
invasion. Gorg et al. [26] stated that sonographic differentia-
tion between benign and malignant pleural lesions was possible
only if solid pleural nodular structures were visible referring to
malignant affections in addition to the belief of pleural line dis-
ruption with poor respiratory movement was a sign of chest
wall invasion. Regarding Yang et al. [27], the minute white
seeds on the pleura, which were visualized by thoracoscopy,
were generally too small to be detected by sonography. Some-
times a diffuse irregular thickening of the parietal, less often of
the visceral pleura was seen.
Alas, in our study echoinvasion and destruction of normal
tissue architecture and blood vessels displacement were more
common in malignant than nonmalignant subgroups (24.1%
versus 20.3% for each criterion) but heterogeneous hypoech-
ogenicity predominated in the nonmalignant subgroup
(28.1% versus 22.4%) with a non-signiﬁcant statistical differ-
ence. A prospective study by Herth et al. [28], compared com-
puted tomography and sonography, demonstrated the higher
sensitivity of sonogrpahy in visualizing an invasive situation.
Therefore, in cases of suspected invasion, sonography of the
pleura and chest wall was a mandatory procedure. According
to Suzuki et al. [29], pleural inﬁltration by primary lung cancer
was sonographically characterized by disruption of the pleura,
inﬁltration of the chest wall and ﬁxation of the tumor during
breathing.
A study done by Bradley and Metreweli [30] conﬁrmed that
sonographic evaluation of the juxta-pleural mass had proved
extremely useful in the diagnosis of such a lesion. Its echogenic
shape and movement helped to determine pulmonary from
pleural based lesions and the echogenicity may aid in benign
versus malignant differentiation.
EPG succeeded, in our cases, in diagnosis of 65.4% of
malignant lesions and 13.5% of nonmalignant lesions in group
I as ﬁnal diagnosis while it succeeded in diagnosing 84.4% of
malignant lesions and 22.2% of nonmalignant lesions of group
II. EPG agreed with ﬁnal diagnosis in 75.9% of total cases
studied in conﬁrming malignancy however agreed in 17.2%
in excluding malignancy. EPG established diagnosis in group
I with a success rate of 35% however, established the diagnosis
in group II with a success rate of 56%. Total success rate ofEPG based diagnosis in all studied cases was 45% as shown
in Table 3. So it is likely to say that EPG showed a higher
capability in diagnosing malignant rather than nonmalignant
lesions. A prospective study by Herth et al. [28], found that
success rate of TUS in diagnosing malignant lesions was higher
than CT chest (64% versus 56%, respectively). In our study
EPG ascertained the diagnosis in 21 (17.2%) cases that were
not diagnosed by CT chest with ﬁnal diagnosis as shown in
Table 4.
We found that adding these four predictors (clinical, FOB,
CT chest and EPG) collectively increased the probability of the
diagnosis of malignancy in 67.2% of cases diagnosed with
malignancy and possibility to exclude malignancy in 71.8%
of cases that were nonmalignant with success percentage of
69.7% of total cases as shown in Table 5.
Sensitivity of EPG was higher than CT chest (75.86% and
53.45%, respectively) in the diagnosis of total studied cases
while speciﬁcity of CT chest in total cases studied were higher
than EPG (59.38% and 17.19%, respectively) as shown in
Table 6.Conclusion
Ultrasound has a valuable role in pulmonary practice yet, it
is operator-dependent. Pleural and peripheral pulmonary le-
sions can be characterized as regards benignancy and malig-
nancy by compound ultrasonographic criteria with
sensitivity of 75.86% and speciﬁcity of 17.19% with an
accuracy of 45.08%. US has a number of advantages over
CT including bedside approach, lower cost, and no radiation
exposure, better manipulation for severely ill patients,
mechanically ventilated and crippled cases who has limited
mobility and in less equipped institutes in addition to the
ability to scan variable layers and to visualize lung move-
ment during respiration.
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